Ombetoxabart is a humanized IgG1-κ monoclonal antibody targeting TcdB ( Clostridioides difficile toxin B), which exerts its function by neutralizing the toxicity of TcdB. Ombetoxabart can be used for the study of Clostridioides difficile infection [1].
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
















